Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

Pulsed radiofrequency vs. 5% dextrose injection for chronic plantar fasciitis

Official title: Comparison of Ultrasound-Guided Pulsed Radiofrequency and 5% Dextrose Injection in Patients With Chronic Plantar Fasciitis: A Randomized Controlled Trial

Run by Ankara City Hospital Bilkent · NCT07688876 · Data updated 2026-11-12

This study tests whether ultrasound-guided pulsed radiofrequency or ultrasound-guided 5% dextrose injections help adults with long-lasting plantar fasciitis who haven’t improved with basic care.

More Plantar Fasciitis trials

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment50 (estimated)
SponsorAnkara City Hospital Bilkent
Academic / other
Locations1 site (Ankara)
StatusRecruiting
StartedJanuary 1, 2026
Main results expectedJanuary 1, 2027
Study endsJanuary 1, 2027
Registry record updatedJuly 7, 2026
Trial IDNCT07688876 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–70 with chronic plantar fasciitis lasting at least 12 weeks and resistant to conservative care.

Probably not a fit

Patients with active infections, bleeding risks, skin disease at the treatment site, prior plantar fasciitis surgery, or inability to adhere to follow-up may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, two-center randomized trial compares two ultrasound-guided injections for chronic plantar fasciitis: pulsed radiofrequency and 5% dextrose injection using the peppering technique. Participants are randomly assigned in equal numbers to each arm and all receive a home plantar fascia stretching program. Outcomes are measured at baseline, 3, 6, and 12 weeks, focusing on pain intensity as the primary endpoint and including function and quality of life as secondary endpoints. Blinding of patients and outcome assessors is attempted, while treatment providers cannot be blinded due to the nature of the interventions. The study aims to determine which approach more effectively reduces pain and improves function in adults with chronic heel pain due to plantar fasciitis.

Why it matters

Potential benefit: If successful, patients may experience greater pain relief and improved foot function with one of the treatments, potentially reducing disability from chronic plantar fasciitis.

How similar studies have gone: Previous studies have explored regenerative injections and neuromodulation for plantar fasciitis, but direct head-to-head data between pulsed radiofrequency and dextrose injections remains limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of chronic plantar fasciitis based on medical history and physical examination
* Heel pain resistant to conservative treatment for at least 12 weeks
* Age between 18 and 70 years
* Willingness to participate in the study and provide written informed consent

Exclusion Criteria:

* Congenital or acquired disease that may impair or prevent foot function, such as rheumatoid arthritis, hemiplegia, congenital foot deformity, traumatic foot or leg amputation, or fracture sequelae
* Local infection or skin disease at the treatment site
* Bleeding disorder or use of anticoagulant medication within the last week
* Disease causing mental dysfunction, such as uncontrolled Parkinson disease or Alzheimer disease
* Previous surgery for plantar fasciitis
* Refusal to participate in the study or inability to provide informed consent
* Failure to attend follow-up visits after treatment
* Request to withdraw from the study
* Pregnancy or suspected pregnancy
* Presence of a cardiac pacemaker
* History of epilepsy
* Active or previous malignancy
* Rheumatologic disease

Where it's running

  • Ankara Bilkent City Hospital, Physical Medicine and Rehabilitation Hospital
    Ankara, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.